Citations

Showing 10 of 108152 citations.

Multi-facet Contextual Bandits
Ban, Yikun , He, Jingrui , Cook, Curtiss B.

Mayo Clinic

Proceedings of the 27th ACM SIGKDD Conference on Knowledge Discovery & Data Mining | August 13, 2021 | Volume: No volume available | Issue: No issue available | Pages: 35-45

10.1145/3447548.3467299 Get It

A systems‐level analysis highlights microglial activation as a modifying factor in common epilepsies
Altmann, André , Ryten, Mina , Nunzio, Martina Di , Ravizza, Teresa , Reynolds, Regina H. , Somani, Alyma, Bacigaluppi, Marco , Iori, Valentina , Sapia, Rossella Di , Cerovic, Milica , Palma, Eleonora , Ruffolo, Gabriele , Botía, Juan A. , Absil, Julie , Alhusaini, Saud , Alvim, Marina K. M. , Auvinen, Pia, Bartolini, Emanuele , Bender, Benjamin , Bergo, Felipe P. G. , Bernardes, Tauana, Bernasconi, Andrea , Bernasconi, Neda , Bernhardt, Boris C. , Blackmon, Karen , Braga, Bárbara , Caligiuri, Maria Eugenia , Calvo, Anna, Carr, Sarah J. A. , Cavalleri, Gianpiero L. , Chen, Jian , Chen, Shuai , Cherubini, Andrea , Concha, Luis , David, Philippe, Delanty, Norman, Depondt, Chantal, Doherty, Colin P. , Domín, Martin , Foley, Sonya , França, Wendy, Gambardella, Antonio , Guerrini, Renzo , Hamandi, Khalid , Hibar, Derrek P., Isaev, Dmitry , Jahanshad, Neda , Kälviäinen, Reetta , Keller, Simon S. , Kotikalapudi, Raviteja , Kwan, Patrick , Langner, Sönke , Lenge, Matteo , Martin, Pascal , Meletti, Stefano , Morita‐Sherman, Marcia , Pariente, José C. , Richardson, Mark P. , Rummel, Christian , Saavalainen, Taavi, Semmelroch, Mira , Striano, Pasquale, Thesen, Thomas , Thomas, Rhys H. , Tondelli, Manuela , Vaudano, Anna Elisabetta , Vivash, Lucy , Podewils, Felix von , Wagner, Jan , Weber, Bernd , Wiest, Roland , Yasuda, Clarissa Lin , Zhang, Junsong , Group, ENIGMA‐Epilepsy Working, Leu, Costin , Avberšek, Andreja , Whelan, Christopher D. , Thompson, Paul M. , McDonald, Carrie R. , Di Sapia, Rossella , Bender, Benjamin , Severino, Mariasavina , Thom, Maria , Yasuda, Clarissa L , Doherty, Colin P , Cavalleri, Gianpiero L , Weber, Bernd , Thompson, Paul M , Richardson, Mark P , Guerrini, Renzo , Thomas, Rhys H , Leu, Costin , Tolomeo, Daniele , Micotti, Edoardo , Bargalló, Núria , Carlson, Chad , Cendes, Fernando , Devinsky, Orrin , Focke, Niels K. , Jackson, Graeme D. , Kochunov, Peter V , Kowalczyk, Magdalena A. , Kuzniecky, Ruben , Labate, Angelo , Liu, Min , Mascalchi, Mario , Morita, Márcia Elisabete , O’Brien, Terence J. , Rodríguez‐Cruces, Raúl , Tortora, Domenico , Zhang, Guohao , Group, ENIGMA‐Epilepsy Working, Vezzani, Annamaria , Sisodiya, Sanjay

Mayo Clinic

Neuropathology and Applied Neurobiology | August 13, 2021 | Volume: 48 | Issue: 1 | Pages: No page available

10.1111/nan.12758 | PMID 34388852 Get It

Abstract Aims The causes of distinct patterns of reduced cortical thickness in the common human epilepsies, detectable on neuroimaging and with important clinical consequences, are unknown. We investigated the underlying mechanisms of cortical thinning using a systems‐level analysis. Methods Imaging‐based cortical structural maps from a large‐scale epilepsy neuroimaging study were overlaid with highly spatially resolved human brain gene expression data from the Allen Human Brain Atlas. Cell‐type deconvolution, differential expression analysis and cell‐type enrichment analyses were used to identify differences in cell‐type distribution. These differences were followed up in post‐mortem brain tissue from humans with epilepsy using Iba1 immunolabelling. Furthermore, to investigate a causal effect in cortical thinning, cell‐type‐specific depletion was used in a murine model of acquired epilepsy. Results We identified elevated fractions of microglia and endothelial cells in regions of reduced cortical thickness. Differentially expressed genes showed enrichment for microglial markers and, in particular, activated microglial states. Analysis of post‐mortem brain tissue from humans with epilepsy confirmed excess activated microglia. In the murine model, transient depletion of activated microglia during the early phase of the disease development prevented cortical thinning and neuronal cell loss in the temporal cortex. Although the development of chronic seizures was unaffected, the epileptic mice with early depletion of activated microglia did not develop deficits in a non‐spatial memory test seen in epileptic mice not depleted of microglia. Conclusions These convergent data strongly implicate activated microglia in cortical thinning, representing a new dimension for concern and disease modification in the epilepsies, potentially distinct from seizure control.
Inertial Measurement Unit–Derived Ergonomic Metrics for Assessing Arm Use in Manual Wheelchair Users With Spinal Cord Injury: A Preliminary Report
Straaten, Meegan G. Van , Goodwin, Brianna M. , Cain, S. M. , Lennon, Ryan J. , Murthy, Naveen S. , Morrow, Melissa M. , Cain, Stephen M. , Barlow, Jonathan D. , Morrow, Melissa M B, Morrow, Melissa M , Cain, Stephen , Jahanian, Omid

Mayo Clinic

Topics in Spinal Cord Injury Rehabilitation | August 13, 2021 | Volume: 27 | Issue: 3 | Pages: 12-25

10.46292/sci20-00059 | PMID 34456543 Get It

Background: Individuals with spinal cord injury (SCI) who use manual wheelchairs (MWCs) have a higher rate of rotator cuff pathology progression than able-bodied individuals. Objectives: This study aimed to test the ability of risk and recovery metrics of arm use to differentiate between (1) MWC users with SCI and matched able-bodied participants (cross-sectional matched-sample study) and (2) MWC users with rotator cuff pathology progression over 1 year from those without pathology progression (longitudinal study). Methods: Thirty-four MWC users and 34 age- and sex-matched able-bodied individuals were recruited. Upper arm risk (humeral elevation >60°) and recovery (static ≥5 seconds and humeral elevation <40°) metrics were calculated from wireless inertial measurement units (IMUs) worn on the upper arms and torso in the free-living environment. Two separate magnetic resonance imaging studies were completed and assessed for a subset of 16 MWC users approximately 1 year apart. Results: The frequency of risk events ( p = .019), summated duration of recovery events ( p = .025), and duration of each recovery event ( p = .003) were higher for MWC users than able-bodied participants. The summated duration of risk events ( p = .047), frequency of risk events ( p = .027), and risk to recovery ratio ( p = .02) were higher and the summated duration of recovery events ( p = .036) and frequency of recovery events ( p = .047) were lower for MWC users with rotator cuff pathology progression ( n = 5) compared to those without progression ( n = 11). Conclusion: IMU-derived metrics quantifying arm use at postures >60° and risk to recovery ratios may provide insights of potential risk factors for rotator cuff pathology progression.
Effect of eliminating pre‐discharge transthoracic echocardiogram on outcomes after TAVR
Welle, Garrett A. , El‐Sabawi, Bassim , Thaden, Jeremy J. , Greason, Kevin L. , Klarich, Kyle W. , Gulati, Rajiv , Rihal, Charanjit S. , Eleid, Mackram F. , Alkhouli, Mohamad A, Eleid, Mackram F , Welle, Garrett A , Nkomo, Vuyisile T. , Alkhouli, Mohamad , Guerrero, Mayra , Crestanello, Juan A. , Rihal, Charanjit S.

Mayo Clinic

Catheterization and Cardiovascular Interventions | August 13, 2021 | Volume: 99 | Issue: 3 | Pages: 861-866

10.1002/ccd.29929 | PMID 34388299 Get It

AbstractObjectivesThe aim of this study was to determine the safety of eliminating the pre‐discharge transthoracic echocardiogram (TTE) on 30‐day outcomes in patients undergoing transcatheter aortic valve replacement (TAVR).BackgroundTTE is utilized before, during, and after TAVR. Post‐procedural, pre‐discharge TTE assists in assessment of prosthesis function and detection of clinically significant paravalvular leak (PVL) after TAVR.MethodsPatients who underwent TAVR at Mayo Clinic from July 2018 to July 2019 were included in a prospective institutional registry. Patients undergoing TAVR prior to February 2019 received a pre‐discharge TTE, while those undergoing TAVR after February 2019 did not. Both cohorts were evaluated with TTE at 30 days post‐TAVR.ResultsA total of 330 consecutive patients were included. Of these, 160 patients (age 81.1 ± 7.6) had routine pre‐discharge TTE, while 170 patients (age 78.9 ± 7.5) were dismissed without routine pre‐discharge TTE. Mortality at 30 days was similar between the two groups (0% and 1.2%, respectively). One episode of PVL requiring intervention (0.6%) occurred in the pre‐discharge TTE group and none in the group without pre‐discharge TTE at 30‐day follow‐up. There was a similar incidence of total composite primary and secondary adverse events between the cohort receiving a pre‐discharge TTE and those without (28.1% vs. 25.3%, P = 0.56) at 30 days. The most common event was need for permanent pacemaker or ICD implantation in both groups (13.1% vs. 11.8%, P = 0.71).ConclusionsElimination of the pre‐discharge TTE is safe and associated with comparable 30‐day outcomes to routine pre‐discharge TTE. These findings have implication for TAVR practice cost‐efficiency and health care utilization.
Characterization and Outcomes of Hospitalized Children With Coronavirus Disease 2019: A Report From a Multicenter, Viral Infection and Respiratory Illness Universal Study (Coronavirus Disease 2019) Registry
Bhalala, Utpal , Boman, Karen , Kumar, Vishakha K. , Retford, Lynn, Blatz, Allison M. , Dapul, Heda , Sayed, Imran A., Gharpure, Varsha , Irby, Katherine , Sanders, Ronald C., Heneghan, Julia A. , Thomas, Melissa K., Gupta, Manoj , Oulds, Franscene, Arteaga, Grace M. , Levy, Emily R. , Gupta, Neha , Kaufman, Margit, AbdelAty, Amr M. , Shlomovich, Mark , O'Meara, A M Iqbal, Kuehne, Joshua, Menon, Shina , Khandhar, Paras B., Miller, Aaron S., Barry, Suzanne, Danesh, Valerie , Zammit, Kimberly, Stulce, Casey , McGonagill, Patrick W. , Bercow, Asher, Amzuta, Ioana, Gupta, Sandeep , Almazyad, Mohammed , Pierre, Louisdon , Sendi, Prithvi , Ishaque, Sidra , Nawathe, Pooja , Lyons, Patrick G. , Bello, Imam Wada , Ari, Judith Ben, Kovačević, Tanja , Bansal, Vikas, Brinton, John T. , Rk, Kashyap, Bansal, Vikas , Kovačević, Tanja , Tierney, David M. , Polić, Branka , Markić, Joško , Asghar, Muhammad Sohaib , Galet, Colette , Carev, Dominko , Wen, Andy , Karam, Oliver , Bansal, Vikas , Levy, Emily R , Gharpure, Varsha P , Asghar, Muhammad S , Karam, Oliver , Gist, Katja M. , Tripathi, Sandeep , Chiotos, Kathleen , Verma, Sourabh , Bjornstad, Erica C. , Tofil, Nancy M. , Abdelaty, Amr, Medar, Shivanand , Khanna, Ashish , Anderson, Harry L, Akhter, Murtaza , Chen, Catherine , Walkey, Allan J. , Bihorac, Azra , Zimmerman, Jerry J. , Menon, Shina

Mayo Clinic

Critical Care Medicine | August 13, 2021 | Volume: 50 | Issue: 1 | Pages: e40-e51

10.1097/ccm.0000000000005232 | PMID 34387240 Get It

Objectives: Multicenter data on the characteristics and outcomes of children hospitalized with coronavirus disease 2019 are limited. Our objective was to describe the characteristics, ICU admissions, and outcomes among children hospitalized with coronavirus disease 2019 using Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study: Coronavirus Disease 2019 registry. Design: Retrospective study. Setting: Society of Critical Care Medicine Viral Infection and Respiratory Illness Universal Study (Coronavirus Disease 2019) registry. Patients: Children (< 18 yr) hospitalized with coronavirus disease 2019 at participating hospitals from February 2020 to January 2021. Interventions: None. Measurements and Main Results: The primary outcome was ICU admission. Secondary outcomes included hospital and ICU duration of stay and ICU, hospital, and 28-day mortality. A total of 874 children with coronavirus disease 2019 were reported to Viral Infection and Respiratory Illness Universal Study registry from 51 participating centers, majority in the United States. Median age was 8 years (interquartile range, 1.25–14 yr) with a male:female ratio of 1:2. A majority were non-Hispanic (492/874; 62.9%). Median body mass index (n = 817) was 19.4 kg/m2 (16–25.8 kg/m2), with 110 (13.4%) overweight and 300 (36.6%) obese. A majority (67%) presented with fever, and 43.2% had comorbidities. A total of 238 of 838 (28.2%) met the Centers for Disease Control and Prevention criteria for multisystem inflammatory syndrome in children, and 404 of 874 (46.2%) were admitted to the ICU. In multivariate logistic regression, age, fever, multisystem inflammatory syndrome in children, and pre-existing seizure disorder were independently associated with a greater odds of ICU admission. Hospital mortality was 16 of 874 (1.8%). Median (interquartile range) duration of ICU (n = 379) and hospital (n = 857) stay were 3.9 days (2–7.7 d) and 4 days (1.9–7.5 d), respectively. For patients with 28-day data, survival was 679 of 787, 86.3% with 13.4% lost to follow-up, and 0.3% deceased. Conclusions: In this observational, multicenter registry of children with coronavirus disease 2019, ICU admission was common. Older age, fever, multisystem inflammatory syndrome in children, and seizure disorder were independently associated with ICU admission, and mortality was lower among children than mortality reported in adults.
A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease
Cheifetz, Adam S. , Afif, Waqqas , Dubinsky, Marla C. , Loftus, Edward V. , Osterman, Mark T. , Saroufim, Ariana, Yarur, Andrés , Melmed, Gil , Papamichael, Konstantinos , Loftus, Edward V , Melmed, Gil Y , Yarur, Andres J , Abreu, María T. , Cross, Raymond K. , Siegel, Corey A

Mayo Clinic

American Journal of Gastroenterology | August 13, 2021 | Volume: 116 | Issue: 10 | Pages: 2014-2025

10.14309/ajg.0000000000001396 | PMID 34388143 Get It

Therapeutic drug monitoring (TDM) of biologics is a rapidly evolving field. We aimed to provide a consensus statement regarding the clinical utility of TDM for biologics in inflammatory bowel disease (IBD). A modified Delphi method was applied to develop consensus statements. A comprehensive literature review was performed regarding TDM of biologic therapies in IBD, and 45 statements were subsequently formulated on the potential application of TDM in IBD. The statements, along with literature, were then presented to a panel of 10 gastroenterologists with expertise in IBD and TDM who anonymously rated them on a scale of 1–10 (1 = strongly disagree and 10 = strongly agree). An expert consensus development meeting was held virtually to review, discuss, refine, and reformulate statements that did not meet criteria for agreement or that were ambiguous. During the meeting, additional statements were proposed. Panelists then confidentially revoted, and statements rated ≥7 by 80% or more of the participants were accepted. During the virtual meeting, 8 statements were reworded, 7 new statements were proposed, and 19 statements were rerated. Consensus was finally reached in 48/49 statements. The panel agreed that reactive TDM should be used for all biologics for both primary nonresponse and secondary loss of response. It was recommended that treatment discontinuation should not be considered for infliximab or adalimumab until a drug concentration of at least 10–15 μg/mL was achieved. Consensus was also achieved regarding the utility of proactive TDM for anti–tumor necrosis factor therapy. It was recommended to perform proactive TDM after induction and at least once during maintenance. Consensus was achieved in most cases regarding the utility of TDM of biologics in IBD, specifically for reactive and proactive TDM of anti–tumor necrosis factors.
CD274 ( PD-L1 ) Copy Number Changes (Gain) & Response to Immune Checkpoint Blockade Therapy in Carcinomas of the Urinary Tract
Gupta, Sounak , Zhang, Yanming , Tickoo, Satish K. , Fine, Samson W. , Gopalan, Anuradha , Chen, Ying‐Bei , Teo, Min Yuen , Funt, Samuel A. , Bajorin, Dean F. , Ross, Dara S. , Ladanyi, Marc , Cheville, John C. , Solit, David B. , Reuter, Victor E. , Teo, Min Y , Vanderbilt, Chad , Sirintrapun, Sahussapont Joseph , Iyer, Gopa , Rosenberg, Jonathan E , Bochner, Bernard H. , Pietzak, Eugene J , Al-Ahmadie, Hikmat A

Mayo Clinic

Bladder Cancer | August 13, 2021 | Volume: 7 | Issue: 4 | Pages: 395-400

10.3233/blc-201532 | PMID 35071713 Get It

BACKGROUND: Immune checkpoint inhibitors are an important therapeutic option for urothelial carcinoma, but durable responses are achieved in a minority of patients. Identifying pre-treatment biomarkers that may predict response to these therapies or who exhibit intrinsic resistance, is of paramount importance. OBJECTIVE: To explore the prevalence of PD-L1 copy number alteration in urothelial carcinoma and correlate with response to immune checkpoint inhibitors. METHODS: We analyzed a cohort of 1050 carcinomas of the bladder and upper urinary tract that underwent targeted next generation sequencing, prospectively. We assessed PD-L1 protein expression, copy number status (next generation sequencing/FISH), and detailed treatment response. RESULTS: We identified 9 tumors with PD-L1 amplification and 9 tumors with PD-L1 deletion. PD-L1 protein expression was the highest in PD-L1 amplified tumors. Of the 9 patients whose tumors harbored PD-L1 amplification, 6 received immunotherapy with 4 deriving clinical benefit, and 2 achieving durable response. Of the 9 patients whose tumors had PD-L1 copy number losses, 4 received immunotherapy with 3 experiencing disease progression. CONCLUSIONS: PD-L1 copy number alterations may serve as potential biomarkers of response to immunotherapy in urothelial carcinoma patients, if validated in larger cohorts.
Pseudo‐Wilsonian Crisis in a ATP7B Heterozygote
Khan, Mohammad Qasim , Chin, Jerry Yung‐Lun , Azhari, Hassan, Rosen, Charles B. , Leise, Michael D. , Khan, Mohammad Qasim

Mayo Clinic

Liver Transplantation | August 13, 2021 | Volume: 28 | Issue: 1 | Pages: 131-133

10.1002/lt.26263 | PMID 34388305 Get It

Response to “Safety and effectiveness of SARS‐CoV‐2 vaccines: A systematic review and meta‐analysis”
Deng, Jiawen , Heybati, Kiyan , Zhou, Fangwen , Deng, J , Zhou, F

Mayo Clinic

Journal of Medical Virology | August 13, 2021 | Volume: 93 | Issue: 12 | Pages: 6477-6478

10.1002/jmv.27269 | PMID 34387877 Get It

Effects of Subnormothermic Regulated Hepatic Reperfusion on Mitochondrial and Transcriptomic Profiles in a Porcine Model
Kim, Joohyun , Zimmerman, Michael A. , Shin, Woo Young , Boettcher, Brent T. , Park, Jong‐In , Ali, M. Syed, Mishra, Jyotsna , Hagen, Catherine E. , McGraw, Joseph , Woehlck, Harvey J. , Lomberk, Gwen , Camara, Amadou K.S. , Stowe, David F. , Hong, Johnny C. , Lomberk, Gwen L , Hagen, Catherine E , Lee, Ju‐Seog , Ali, Muhammed, Yang, Meiying , Mathison, Angela , Urrutia, Raúl

Mayo Clinic

Annals of Surgery | August 13, 2021 | Volume: 277 | Issue: 2 | Pages: e366-e375

10.1097/sla.0000000000005156 | PMID 34387201 Get It

Objective: We sought to investigate the biological effects of pre-reperfusion treatments of the liver after warm and cold ischemic injuries in a porcine donation after circulatory death model. Summary of Background Data: Donation after circulatory death represents a severe form of liver ischemia and reperfusion injury that has a profound impact on graft function after liver transplantation. Methods: Twenty donor pig livers underwent 60 minutes of in situ warm ischemia after circulatory arrest and 120 minutes of cold static preservation prior to simulated transplantation using an ex vivo perfusion machine. Four reperfusion treatments were compared: Control-Normothermic (N), Control- Subnormothermic (S), regulated hepatic reperfusion (RHR)-N, and RHR-S (n = 5 each). The biochemical, metabolic, and transcriptomic profiles, as well as mitochondrial function were analyzed. Results: Compared to the other groups, RHR-S treated group showed significantly lower post-reperfusion aspartate aminotransferase levels in the reperfusion effluent and histologic findings of hepatocyte viability and lesser degree of congestion and necrosis. RHR-S resulted in a significantly higher mitochondrial respiratory control index and calcium retention capacity. Transcriptomic profile analysis showed that treatment with RHR-S activated cell survival and viability, cellular homeostasis as well as other biological functions involved in tissue repair such as cytoskeleton or cytoplasm organization, cell migration, transcription, and microtubule dynamics. Furthermore, RHR-S inhibited organismal death, morbidity and mortality, necrosis, and apoptosis. Conclusion: Subnormothermic RHR mitigates IRI and preserves hepatic mitochondrial function after warm and cold hepatic ischemia. This organ resuscitative therapy may also trigger the activation of protective genes against IRI. Sub- normothermic RHR has potential applicability to clinical liver transplantation.